教員別検索	所属別検索		学位論文・関西医大誌

<<< 前 2024年度 | 2025年度 | 2026年度

医学部呼吸器腫瘍内科学講座

■ 当該年度研究業績数一覧表 研究者名 論文 著書 学会発表 その他 発表 和文 英文 和文 英文 国内 国際 筆 頭 共 著 筆 頭 共 著 筆 頭 共 著 筆 頭 共 著 演 者 共 演 演 者 共 演 演 者 共 演 倉田　宝保   教授  0  0  0  3  0  0  0  0  0  0  0  0  0  0 本津　茂人   診療教授  0  0  0  0  0  0  0  0  0  0  0  0  0  0 延山　誠一   准教授  0  0  0  0  0  0  0  0  0  0  0  0  0  0 池田　慧   准教授  2  0  2  2  1  0  0  0  3  0  0  0  0  0 山中　雄太   講師  0  0  0  3  0  0  0  0  0  0  0  0  0  0 金田　俊彦   診療講師  0  0  0  0  0  0  0  0  0  0  0  0  0  0 竹安　優貴   助教  0  0  0  4  0  0  0  0  0  0  0  0  0  0 中濵　かほり   助教  0  0  0  2  0  0  0  0  0  0  0  0  0  0 吉田　清里   助教  0  0  0  2  0  0  0  0  0  0  0  0  0  0 岡﨑　優太   助教  0  0  1  1  0  0  0  0  0  0  0  0  0  0 中西　健太郎   助教  0  0  0  1  0  0  0  0  0  0  0  0  0  0 生駒　龍興   助教  0  0  0  2  0  0  0  0  0  0  0  0  0  0 荒木　啓吾   助教  0  0  0  2  0  0  0  0  0  0  0  0  0  0 北川　真愛   助教  0  0  0  2  0  0  0  0  0  0  0  0  0  0 槇原　なつの   助教  0  0  0  2  0  0  0  0  0  0  0  0  0  0 計  2  0  3  26  1  0  0  0  3  0  0  0  0  0

■ 学術雑誌 原著 1. Takashi Nojiri, Akiisa Omura, Hiroshi Nishimura, Hiroshi Uda, Michihito Katayama, Kiyotsugu Iede, Yuki Takeyasu, Utae Katsushima, Hiroshi Okada, Masahiko Higashiyama：  Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study.  Anticancer research  46 (5) ：2781 -2788 , 2026 2. Haruka Nakatani, Hayato Kawachi, Tadaaki Yamada, Naoki Furuya, Hisashi Tanaka, Akihiro Yoshimura, Tomohiro Oba, Makoto Hibino, Takahito Fukuda, Yasuhiro Goto, Akira Nakao, Shinsuke Ogusu, Yuta Okazaki, Taishi Harada, Takayo Ota, Ken Masubuchi, Koji Mikami, Tae Hata, Kenji Morimoto, Koichi Takayama：  Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance.  Anticancer research  46 (5) ：2789 -2806 , 2026 3. Yasushi Goto, Makoto Nishio, Kadoaki Ohashi, Atsushi Osoegawa, Eiki Kikuchi, Hideharu Kimura, Junichi Shimizu, Eisaku Miyauchi, Hiroshige Yoshioka, Ichiro Yoshino, Toshihiro Misumi, Yasutaka Watanabe, Nobuyuki Katakami, Akira Kisohara, Masafumi Yamaguchi, Hirotaka Kuroki, Masamichi Sugimoto, Hisao Ashimura, Misa Tanaka, Akihiko Gemma：  Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2.  Cancer science  ：Online ahead of print , 2026 4. Taku Itoh, Go Saito, Kazushi Fujimoto, Satoshi Ikeda, Mitsuhiro Abe, Satoshi Hirano, Sukeyuki Nakamura, Akihiro Tamiya, Kyoichi Okishio, Takuji Suzuki.：  Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small cell lung cancer and interstitial lung disease: A multicenter retrospective study.  Cancer treatment and research communications  47 (101197) ：Online ahead of print , 2026 5. Masashi Ishihara, Takahisa Kawamura, Yukiko Namba, Yuki Takeyasu, Yukihiro Hasegawa, Yuki Sato, Yoshiki Negi, Tomohiro Oba, Toshiyuki Sumi, Hirokuni Hirata, Hidemitsu Funabashi, Yuko Oya, Hajime Kikuchi, Motoko Tachihara, Takeshi Nakatani, Taishi Harada, Keiko Tanimura, Taku Nakagawa, Naoya Takeda, Takahiro Asami, Osamu Honjo, Hiromi Nagashima, Takumi Yamaura, Norihiko Hata, Miyako Kitazono, Naoya Nishioka, Akihiro Tamiya, Yuichi Sakamori, Ryota Shigaki, Kyoichi Kaira, Ryoichi Honda, Takashi Matsui, Eriko Suzuki, Kentaro Ito, Kojiro Otsuka, Yuko Yoshizumi, Yusuke Murakami, Kazuhiko Matsuno, Sumito Inoue, Akira Kisohara, Sojiro Kusumoto, Hiroe Aoshima, Yumiko Kakizaki, Akihito Kubo, Akito Hata, Nobuhisa Ishikawa, Kosuke Hamai, Nobuhiro Kanaji, Nobuaki Mamesaya, Toshihiro Misumi, Noriyuki Matsutani, Nobuhiko Seki：  Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for EGFR L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis.  JTO clinical and research reports  7 (4) ：100972 , 2026 6. Ikeda S, Kenmotsu H, Koto R, Hirai T, Ogi M, Sato Y, Iwao C, Kitagawa H, Yamamoto N.：  Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab.  Lung Cancer  Available online 25 May 2026, 109470 , 2026 7. Hidetoshi Hayashi, Byoung Chul Cho, Yu Jung Kim, Se-Hoon Lee, Pongwut Danchaivijitr, Adlinda Alip, Hailin Xiong, Soon-Hin How, Gee-Chen Chang, James Chih-Hsin Yang, Yuta Yamanaka, Mehmet Ali Nahit Şendur, Kumar Prabhash, Koichi Azuma, Alianu Akawung, Elizabeth Fennema, Xiaodan Tang, Sujay Shah, Seema Sethi, Shun Lu：  Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis.  Lung cancer (Amsterdam, Netherlands)  214 ：109305 , 2026 8. Hiroyasu Kaneda, Motoko Tachihara, Yukihiro Toi, Shoichi Kuyama, Eiki Ichihara, Yasuhito Fujisaka, Koichi Azuma, Takayasu Kurata, Akihito Kubo, Hisashi Tanaka, Tadaaki Yamada, Toshihide Yokoyama, Takahide Kato, Ken Yamamoto, Nobuyuki Katakami, Ryota Kawai, Hisako Yoshida, Ayumi Shintani, Kenji Sawa, Tomoya Kawaguchi：  Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion).  Lung cancer (Amsterdam, Netherlands)  ：Online ahead of print , 2026 9. Okazaki Y, Yoshioka H, Ikoma T, Araki K, Makihara N, Kitagawa M, Nagata Y, Fujii K, Okuno Y, Kamisako K, Nakanishi K, Ikeda Y, Yoshida K, Nakahama K, Takeyasu Y, Katsushima U, Yamanaka Y, Ikeda S, Kurata T：  Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.  Respiratory investigation  64 (3) ：101418 , 2026 総説及び解説 1. 池田慧：  切除可能非小細胞肺癌に対する周術期治療（ALK融合遺伝子、EGFR遺伝子変異、その他のドライバー変異）.  医学のあゆみ  297 (5) ：361 -365 , 2026 2. 池田慧：  間質性肺炎合併肺癌（特発性間質性肺炎を再考する StandardとUnmet medical needs）.  呼吸器ジャーナル  74 (2) ：296 -303 , 2026 3. Satoshi Ikeda, Keigo Araki, Mai Kitagawa, Natsuno Makihara, Yutaro Nagata, Kazuki Fujii, Kiyori Yoshida, Tatsuki Ikoma, Kahori Nakahama, Yuki Takeyasu, Utae Katsushima, Yuta Yamanaka, Takayasu Kurata：  Survival, Toxicity, and Sequencing: Navigating the New First-Line Standard Established by FLAURA2.  Translational lung cancer research  15 (4) ：115 , 2026

■ 著書 1. 池田慧, 伊藤健太郎, 阪本智宏, 藤本大智, 松原太一：    肺癌診療実践マニュアル ―WINGの流儀―  1-329.  中外医学社,  東京, 2026

■ 学会発表 全国規模の学会 1. ◎池田慧： 呼吸器疾患患者の社会的苦痛に対するケア.  第66回日本呼吸器学会学術講演会,  神戸,  2026/04 2. ◎池田慧、小倉高志、三角俊裕、西岡安彦、橋本成修、一門和哉、福泉彩、高田佐織、伊藤拓、佐藤悠城、沖塩協一、矢寺和博、坂本憲穂、加藤元康、菊池亮太、本多隆行、橋本直純、菊池崇史、一色琢磨、山根真由香、柄山正人、宮本篤、石田有莉子、猪又峰彦、錦織博貴、山口覚博、網本久敬、田村賢太郎、柳原豊史、谷野功典、神山潤二、靏蒔望、早稲田優子、喜舎場朝雄、小笹裕晃、松本優、木下義晃、中村祐太郎、山内浩義、岸一馬： 間質性肺炎合併非小細胞肺癌患者における遺伝子検査と標的治療に関する全国研究.  第66回日本呼吸器学会学術講演会,  神戸,  2026/04 3. ◎池田慧： T-DXdによるILDの実像と安全管理への挑戦.  第66回日本呼吸器学会学術講演会,  神戸,  2026/04

---